Pilot Study to Determine the Optimal Negative Pressure for Non-invasive Breast Augmentation in Women
Condition: Breast Hypoplasia Interventions: Device: EVERA-RAPHA with 60mmHG; Device: EVERA-RAPHA with 100mmHG Sponsor: Seoul National University Hospital Not yet recruiting
Abstract This review discusses the historical development of smooth and textured silicone gel filled implants, and examines the reasoning behind product development and aspects of surgical technique from a surgeon's perspective. PMID: 31964154 [PubMed - as supplied by publisher]
Simultaneous contralateral augmentation in direct-to-implant (DTI) breast reconstruction may increase the risk of skin flap necrosis on the reconstruction side due to increased tension on the skin flap when implants are larger than the original breast size. The purpose of this study was to evaluate whether the contralateral augmentation procedure affects complications in unilateral DTI breast reconstruction.
: The risk of BIA-ALCL for patients with textured breast implants has been estimated between 1/2832 and 1/30,000 women. Existing studies estimating the numbers exposed and at risk, may have under reported cases, and/or lacked comprehensive follow-up. Our objective is to determine the risk of BIA-ALCL in a defined cohort of patients reconstructed with macro-textured breast implants and consistently followed long-term.
A cancer in women with textured breast implants is more widespread than previously believed, raising questions for patients and physicians about continuing to describe it as "rare."
During the last two decades, the number of breast implants used in aesthetic, oncologic and risk reducing surgery has exponentially increased. Since the identification of the first case of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) more than twenty years ago , several cases on this very rare disease have been reported, demonstrating a clear association with breast implants. As a result, the World Health Organization (WHO) recognized BIA-ALCL as a disease associated with excellent outcomes in the 2017 classification of haemato-lymphoid neoplasms .
WARNING, GRAPHIC CONTENT: Angelica Isaksen, from Sweden, paid £5,940 for her second breast enhancement last June. She claims her right implant began falling out after two weeks.
AbstractBackgroundA large number of clinical studies have suggested that acellular dermal matrix (ADM) can decrease the incidence of capsular contracture in implant-based breast reconstruction. Yet, there is currently no high-level epidemiological evidence to prove this. The goal of this meta-analysis was to clarify the efficacy of ADM in capsular contracture, and provide a reference value for plastic surgeons.MethodsWe systematically performed a search on PubMed, EMBASE, and the Cochrane Library to identify eligible studies from inception up to October 1, 2019. A random-effects model was used to obtain a pooled incidence ...
ConclusionsThe new technique of muscle splitting biplane breast augmentation with internal mastopexy type II or MSBBA-IM2 offers improved long-term aesthetic results and is an effective alternative in selected patients requiring correction of breast hypoplasia associated with excessive or loose skin envelope or breast ptosis grade I.Level of Evidence IVLevel of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266.
Exclusive: solicitors call for UK ban of textured variety associated with lymphomaAt least 61 women in the UK have been diagnosed with a potentially fatal cancer linked to breast implants, but the type they received continues to be used, with no plans by the regulator to follow France and Australia in banning them.Lawyers for more than 40 of the women, who are bringing legal action against the manufacturers as well as the clinics and doctors who carried out the surgery, say thetextured implants linked toanaplastic large cell lymphoma (ALCL) should be withdrawn from the market. Smooth implants are available instead, which h...
Condition: Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL) Intervention: Other: BIA-ALCL Sponsor: The Lymphoma Academic Research Organisation Recruiting